Caveat emptor: editors beware

Neuropsychopharmacology. 2001 Mar;24(3):333-6. doi: 10.1016/S0893-133X(00)00171-8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Brain / drug effects
  • Clinical Trials as Topic / standards
  • Hallucinogens / adverse effects*
  • Humans
  • N-Methyl-3,4-methylenedioxyamphetamine / administration & dosage
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Nerve Degeneration / chemically induced*
  • Risk
  • Serotonin / metabolism*

Substances

  • Hallucinogens
  • Serotonin
  • N-Methyl-3,4-methylenedioxyamphetamine